Ablation of atrial arrhythmias in heart failure

Philip Aagaard, Luigi Di Biase, Andrea Natale

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

HF and AF are on the rise and often coexist. Pharmacologic rhythm control has not been shown to improve outcomes compared with pharmacologic rate control. It is possible that the benefits of maintaining SR are offset by the adverse effects of AADs. Catheter ablation of AF offers an opportunity to achieve SR without the downside of AADs. Several studies have shown that AF ablation improves prognostic markers, including ventricular function, exercise tolerance, and perceived quality of life in HF patients. Studies addressing the impact of this treatment strategy on cardiovascular outcomes and cost-effectiveness are ongoing.

Original languageEnglish (US)
Pages (from-to)305-317
Number of pages13
JournalHeart Failure Clinics
Volume11
Issue number2
DOIs
StatePublished - Apr 1 2015

Fingerprint

Exercise Tolerance
Catheter Ablation
Ventricular Function
Cost-Benefit Analysis
Cardiac Arrhythmias
Heart Failure
Quality of Life
Therapeutics

Keywords

  • Antiarrhythmic drugs
  • Atrial arrhythmia
  • Atrial fibrillation
  • Atrial fibrillation ablation
  • Heart failure
  • Rate control
  • Rhythm control

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Ablation of atrial arrhythmias in heart failure. / Aagaard, Philip; Di Biase, Luigi; Natale, Andrea.

In: Heart Failure Clinics, Vol. 11, No. 2, 01.04.2015, p. 305-317.

Research output: Contribution to journalArticle

Aagaard, Philip ; Di Biase, Luigi ; Natale, Andrea. / Ablation of atrial arrhythmias in heart failure. In: Heart Failure Clinics. 2015 ; Vol. 11, No. 2. pp. 305-317.
@article{19626d88f4ed4e4bb83fa94391f4e831,
title = "Ablation of atrial arrhythmias in heart failure",
abstract = "HF and AF are on the rise and often coexist. Pharmacologic rhythm control has not been shown to improve outcomes compared with pharmacologic rate control. It is possible that the benefits of maintaining SR are offset by the adverse effects of AADs. Catheter ablation of AF offers an opportunity to achieve SR without the downside of AADs. Several studies have shown that AF ablation improves prognostic markers, including ventricular function, exercise tolerance, and perceived quality of life in HF patients. Studies addressing the impact of this treatment strategy on cardiovascular outcomes and cost-effectiveness are ongoing.",
keywords = "Antiarrhythmic drugs, Atrial arrhythmia, Atrial fibrillation, Atrial fibrillation ablation, Heart failure, Rate control, Rhythm control",
author = "Philip Aagaard and {Di Biase}, Luigi and Andrea Natale",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.hfc.2014.12.008",
language = "English (US)",
volume = "11",
pages = "305--317",
journal = "Heart Failure Clinics",
issn = "1551-7136",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Ablation of atrial arrhythmias in heart failure

AU - Aagaard, Philip

AU - Di Biase, Luigi

AU - Natale, Andrea

PY - 2015/4/1

Y1 - 2015/4/1

N2 - HF and AF are on the rise and often coexist. Pharmacologic rhythm control has not been shown to improve outcomes compared with pharmacologic rate control. It is possible that the benefits of maintaining SR are offset by the adverse effects of AADs. Catheter ablation of AF offers an opportunity to achieve SR without the downside of AADs. Several studies have shown that AF ablation improves prognostic markers, including ventricular function, exercise tolerance, and perceived quality of life in HF patients. Studies addressing the impact of this treatment strategy on cardiovascular outcomes and cost-effectiveness are ongoing.

AB - HF and AF are on the rise and often coexist. Pharmacologic rhythm control has not been shown to improve outcomes compared with pharmacologic rate control. It is possible that the benefits of maintaining SR are offset by the adverse effects of AADs. Catheter ablation of AF offers an opportunity to achieve SR without the downside of AADs. Several studies have shown that AF ablation improves prognostic markers, including ventricular function, exercise tolerance, and perceived quality of life in HF patients. Studies addressing the impact of this treatment strategy on cardiovascular outcomes and cost-effectiveness are ongoing.

KW - Antiarrhythmic drugs

KW - Atrial arrhythmia

KW - Atrial fibrillation

KW - Atrial fibrillation ablation

KW - Heart failure

KW - Rate control

KW - Rhythm control

UR - http://www.scopus.com/inward/record.url?scp=84926102110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926102110&partnerID=8YFLogxK

U2 - 10.1016/j.hfc.2014.12.008

DO - 10.1016/j.hfc.2014.12.008

M3 - Article

C2 - 25834977

AN - SCOPUS:84926102110

VL - 11

SP - 305

EP - 317

JO - Heart Failure Clinics

JF - Heart Failure Clinics

SN - 1551-7136

IS - 2

ER -